Enhancing breast Cancer immunotherapy using gold nanoparticles carrying tumor antigens
Open Access
- 14 May 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Abstract
Cancer immunotherapy combined with standard treatments could provide an effective approach to enhancing anti-tumor responses. Activating antigen-presenting cells, such as dendritic cells (DCs), plays a central role in generating robust anti-tumor immune responses. Freund’s adjuvant together with nanoparticles (NPs) and tumor antigens, promotes significant immune responses and shift antigen-specific T-cell activity from a Th2 to a Th1 response. Herein, Freund’s adjuvant was combined with gold nanoparticles and tumor cell lysate (TCL). The AuNPs exhibited a spherical morphology. The in vitro release studies demonstrated a continuous and gradual release of AuNPs and TCL from Freund’s adjuvant. The immunogenicity studies revealed high levels of cytokine secretion for IFN-γ, IL- 1, IL- 18, and TCD8+, along with reduced levels of IL- 4 cytokine in immunized mouse models in various treatment groups. In the prophylactic group, tumor growth was delayed, while in the therapeutic group, mouse models had more than 85% reduction within 31 days compared to the control group. The tumor size in the combination strategies, shrank to ~ 86% of its first size in just 17 days after treatment, while the control group tumor size increased by approximately 52%. These data suggest that the proposed drug system is an effective anti-tumor vaccine and also potentiate innate or adaptive immune responses for cancer therapy.Keywords
This publication has 50 references indexed in Scilit:
- Positive electrostatic therapy of metastatic tumors: selective induction of apoptosis in cancer cells by pure chargesCancer Medicine, 2021
- Advances in Combining Radiation and Immunotherapy in Breast CancerClinical Breast Cancer, 2021
- Gold nanoparticle-based platforms for vaccine developmentDrug Discovery Today: Technologies, 2020
- Cellular immunotherapy in breast cancer: The quest for consistent biomarkersCancer Treatment Reviews, 2020
- Gold nanoparticles enhance immune responses in mice against recombinant classical swine fever virus E2 proteinBiotechnology Letters, 2020
- Breast Cancer TreatmentJAMA, 2019
- Vaccine adjuvants: smart components to boost the immune systemArchives of Pharmacal Research, 2017
- The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccinesCancer Immunology, Immunotherapy, 2006
- Engineered vascular‐targeting antibody‐interferon‐γ fusion protein for cancer therapyInternational Journal of Cancer, 2005
- Induced hyperthermia in brain tissue: Comparison between contact Nd:YAG laser system and automatically controlled high frequency currentActa Neurochirurgica, 1990